AIMT
Aimmune Therapeutics, Inc.
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
146 hedge funds and large institutions have $1.09B invested in Aimmune Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 55 increasing their positions, 27 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+21
Holders Change %
+16.8%
% of All Funds
3.21%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
43
Increased
55
Reduced
27
Closed
21
Calls
$13M
Puts
$16.2M
Net Calls
-$3.23M
Net Calls Change
-$4.85M
Top Buyers
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$22.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.7M |
| 3 |
Bank of New York Mellon
New York
|
+$13.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$8.75M |
Top Sellers
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$21.6M |
| 2 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$20.1M |
| 3 |
AC
Aisling Capital
New York
|
-$15.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.23M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$7.47M |
